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As key genome regulatory elements, transcription factors (TFs) bind to the DNA to control gene 
expression. High-throughput technologies such as ChIP-seq can experimentally determine TF 
binding; however, the raw data alone cannot fully answer questions such as whether a TF found in 
open chromatin is the one responsible for the relaxed state (thus displaying pioneering properties), 
or it came along and bound an already accessible site. 
In this study we wanted to investigate the interplay between TFs and chromatin accessibility. I used 
ChIPanalyser, a Bioconductor tool, to model and predict ChIP-seq-like profiles in human cell lines, 
based on publicly available ChIP-seq and DNA accessibility datasets. I estimated the binding 
parameters of twenty TFs in IMR90 and HepG2 cell lines and used their profiles to evaluate their 
preference for (or lack of) open and dense chromatin.  
Our analysis supports that there are a number of TFs (e.g. CTCF) that display the same properties 
whether we consider the DNA to be accessible or not, highlighting that some TFs are insensitive to 
chromatin accessibility, and this holds true for regions with weaker binding sites as well as strong. 
Our results also suggest there are subsets of TFs that have a preference for open chromatin (e.g. 
MAZ). Out of the 20 TFs analysed, 4 displayed pioneering functions when looking only at the strong-
bound regions and 3 at both strong and medium-bound regions. These results are true when using 
different accessibility measure methods, like ATAC-seq, DNase-seq, MNase-seq and NOMe-seq, 
hence the results are not method-specific. 
In short, ChIPanalyser can be used to model and predict ChIP-seq data and learn new biological 
insights, to predict TF binding events between cell lines, or for a screening process to understand a 
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5. Introduction  
 
5.1 An overview of transcription factors  
Transcription factors (TFs) are specific regulatory proteins which, by binding to short DNA 
sequences, regulate the transcription of a target gene either positively or negatively in order to 
produce the observed effect on transcription. Indeed, the regulation of gene transcription is key to 
control both an organism’s development by directing tissue-specific gene expression, as well as gene 
activity as a response to stimuli. The short DNA sequences whereby TFs bind are common to genes 
that exhibit the same pattern of expression. This translates into the fact that genes which 
transcription is induced as a response to, for example, an environmental stress such as heat or cold 
stress, will contain a common regulatory element which is absent from genes that do not show this 
pattern of transcription (Latchman, 1997). Given the pivotal role that these regulatory proteins play 
within the genome, their regulation is therefore vital. Their role is in fact essential in a wide variety 
of cellular processes including diseases such as developmental disorders, disorders of the hormone 
response, and cancer (Latchman, 1997). For example, Forkhead box (FOXO) transcription factor has 
a primary role in cancer and metastasis. FOXO TF regulates numerous biological processes including 
development and metabolism. Given its ability to regulate genes essential for cellular processes 
such as division, death, angiogenesis and metastasis, it has also been increasingly recognised as a 
tumour suppressor gene (Jiramongkol and Lam, 2020 and Zaret and Carroll, 2011). By clarifying the 
role and the regulation of FOXO protein in tumour initiation and progression, new therapeutic 
opportunities for tumourigenesis can be explored. 
 
Indeed, disruptions of gene expression and gene regulation, some of which might be linked to the 
binding of the TFs in the first place, have been always associated to various diseases. Being able to 
understand where TFs bind, therefore, means gaining insights into the mechanisms that could lead 
to diseases such as cancer. Understanding TF binding can also be useful for targeting purposes in 
order to repress certain genes that, for instance, are involved with the cell growth of cancerous 
tissues. This targeting exercise could be used to inhibit specific TF:DNA binding as a potential 
therapeutic approach. Hence many efforts and numerous scientific resources have been – and are 
being – invested to delve in the complexion of TFs. This link in the chain is useful to understand the 
bigger picture of how cells work (fig. 1). By unravelling their binding mechanisms to the DNA one 
could get to the heart of gene regulatory networks (GNRs), where molecular regulators such as DNA, 
RNA and proteins interact with each other. All the positive and negative feedback interactions of 
many genes govern gene expression levels within the cell, eventually determining the function of 
the cell (Cussat-Blanc et al., 2019, and Latchman, 1996). 
 








Figure 1: understanding the bigger picture of TF:DNA binding mechanisms. 
































5.2 Transcription factor classification 
Proteins bind to DNA through different types of interactions and they do so in a sequence-specific 
or non-sequence-specific manner (Wieczór and Czub, 2017). In order to understand the functions 
that these complexes play in regulating cellular processes, it is essential to classify these proteins 
based on their binding properties, e.g. the ability of binding to areas of dense chromatin, which 
would distinguish an accessibility dependent factor (such as a traditional TF) from an accessibility 
independent one (such as a pioneer TF), or again the ability to make DNA accessible to other 
proteins, which is the difference between a pioneer factor and a chromatin insulator (Wingender et 
al., 2014). The hypothesis that the distinguishing trait between the different classes of TFs was their 
potential role in chromatin binding and chromatin opening was investigated in a recent study by 
Ehsani et al. in 2016. They concluded that each subclass of TFs was enriched for properties that 
seemed to characterise the subclass relative to its role in gene regulation. This means that TF 
classification is given based on the TF’s binding properties that subsequently give rise to a specific 
gene regulation pattern. Sherwood et al. in 2014 identified binding sites for over 700 TFs using a 
computational method to model the magnitude and shape of genome-wide DNase I hypersensitivity 
profiles used for identification of TF binding sites; based on the classification they proposed, in this 
project TFs have been grouped in three categories: AIFs (accessibility independent factors), ADFs 
(accessibility dependent factors) and IDFs (inaccessibility dependent factors). 
 
1) AIFs include pioneers (and their co-factors) and chromatin remodelers (and their co-factors). 
They are capable of binding to DNA target sites – known as transcription factor binding sites 
or TFBSs – even in areas of inaccessible regions (heterochromatin, where chromatin is 
compacted and therefore inaccessible to most TFs). This event increases chromatin 
accessibility via nucleosome remodelling, therefore facilitating recruitment of other TFs that 
would otherwise be unable to access dense chromatin (Vanzan et al., 2021). They were 
described as proteins which can bind to compacted chromatin and can promote chromatin 
modification events required for gene activation by Cirillo et al. (2002). Moreover, AIFs have 
been found to be bound to these areas of dense chromatin even before activation of 
enhancers, which modulate gene expression (Pennacchio et al., 2013). Thus, AIFs can foster 
subsequent access to classical non-pioneer TFs to their target sites (Soufi et al., 2015). 
 
AIFs, compared to the other TF classes, are the ones that display the strongest and most 
specific DNA binding (Ehsani et al., 2016). The other characteristic that makes AIFs essential 
to gene expression regulation is their ability to relax the chromatin so as to make 
heterochromatin become accessible for non-pioneers to bind. AIFs are therefore proteins 
that can relax closed chromatin (Mayran et al., 2019) and can open up a pathway to recruit 
other factors, which will subsequently trigger gene transcription. An example of a known 
family of AIFs is the FOXO family (Zaret and Carroll, 2011). Table 1 shows a summary of most 
of the validated or predicted pioneer TFs in humans in the literature so far. In terms of ChIP-
seq signals, AIFs’ peaks will only ever be found in open chromatin, whether DNA is dense or 
not, because if there are no predicted peaks in dense chromatin, it means that the TF was 
able to open the chromatin wherever it bound. 
 
2) ADFs include traditional factors (and their co-factors) and rely on the chromatin to be 
inheritably opened from a previous state (for example if a genomic region was accessible 
throughout the entire organism’s development), or if the chromatin has been already 
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opened by an accessibility independent TF, as described in the above paragraph (Vandel et 
al., 2019). This is because they are not able to bind to inaccessible DNA regions, therefore 
the only way they can work is if an accessibility independent factor has previously made the 
chromatin accessible (Magnani, 2011). ADFs will therefore only bind to accessible DNA and 
will not change the chromatin accessibility state post binding. There is also a subclass of ADFs 
which binds just sporadically to the DNA, even when chromatin at their target sites is fully 
opened (Sherwood et al., 2014). ADFs, therefore, do not exhibit highly-specific DNA binding 
properties: they are the standard transcriptional machinery and will be there every time 
there is gene activation. Their ChIP peaks will be found mainly in open chromatin. However, 
if the DNA was considered dense, they could also bind to dense regions, if they were opened 
by an AIF. 
 
3) Furthermore, recent studies have hypothesised other genomic elements that play a pivotal 
role in the establishment, maintenance and regulation of the specific chromatin states; (i.e. 
the three-dimensional chromatin organization within the nucleus of eukaryotic cells that 
takes place at the level of the 10 nm fibre, crucial for proper gene expression during 
development (Phillips and Corces 2009)), are the IDFs, which include chromatin insulators 
and their co-factors (Yang and Corces, 2011). IDFs will preferentially bind to dense 
chromatin, but they will also bind accessible regions in presence of an AIF, therefore they 
display high levels of binding in areas of dense chromatin and low to medium levels of 
binding in areas of open chromatin. The difference is that whilst AIFs will relax dense 
chromatin, IDFs will reinforce it, by blocking the interactions between promoters and 
enhancers, other than performing diverse regulatory functions (Song et al., 2011). A 
chromatin insulator consists of a DNA sequence that is capable of mediating intra- and inter-
chromosomal interactions, thereby being partly responsible for the 3D folding of chromatin 
(Phillips-Cremins and Corces, 2013). This is obtained via two main mechanisms of action 
(Allison, 2012). The first is observed when the insulator is found between the enhancer and 
the promoter. In this case, enhancer-blocking IDFs work by interfering the enhancer’s ability 
to interact with the gene promoter (West, 2002). The second case consists in barrier 
insulators stopping the spreading of heterochromatin, thereby preventing gene silencing 
and gene inactivation. They do so by recruiting histone modifying enzymes (Wang et al., 
2014), which are genomic elements heavily involved in the control of gene expression, by 
catalyzing the modification, by addition or removal, of a number of histones and non-histone 
proteins (Marmorstein and Trievel, 2009). 
 
IDFs are also involved with diseases: as a consequence of a disruption in the extremely 
complex network of nuclear organization that chromatin insulators are a part of, which 
contributes to differential gene expression during cell differentiation, development of 
cancer or other diseases might be observed (Yang and Corces, 2011). An example of a known 
IDF is the CCCTC-binding factor, or CTCF (Phillips and Corces, 2009). This TF is involved in 
numerous regulatory functions, including transcriptional activation and repression. Among 
these, we find X chromosome inactivation, the chief and unique dosage compensation 
mechanism whereby, in a highly controlled and coordinated way, female of mammals 
transcriptionally silence one of their X chromosomes. This is achieved in order to correct the 
imbalance of having two gene-rich X chromosomes compared to males who carry one gene-
poor (Y) and one gene-rich (X) chromosome (Ahn and Lee, 2008). IDFs’ preferentially bind 
dense chromatin however, if the DNA is considered accessible, there could potentially be 
some binding there as well. IDFs bind chromatin in three different scenarios (fig. 2b): (i) 
9 
 
dense chromatin is bound and maintained; (ii) dense chromatin is bound and reinforced, 
thus the number of nucleosomes in that genomic region is increased; and lastly (iii) open 
chromatin is bound and then becomes compacted. Is it difficult to distinguish between the 
three cases from ChIP data alone since what we observe is that, after binding, the TF is 
located in dense chromatin and we do not know if the chromatin was already closed and the 
TF is there to maintain it (first case) or it is responsible for the strengthening or compaction 
of the chromatin (second and third scenario). An example of a IDF that would behave like 
example iii) is CTCF: due to its diverse functions, CTCF does present binding regions in open 
chromatin. However, by binding with target sequences, CTCF can act as an IDF by both 
blocking interactions between enhancers and promoters as well as preventing 
heterochromatin expansion, effectively acting as a chromatin barrier (Rojano, Seoane, 
Ranea and Perkins, 2018). 
 
In conclusion, the three main classes of TFs are AIFs, ADFs and IDFs (fig. 2a), each with their 
respective binding properties (fig. 2b). Characterisation is given by how differently they bind to 
chromatin. Based on the TF class, prediction of gene expression patterns can be attempted. Each 






Figure 2: the 3 main classes of TFs are AIFs, ADFs and IDFs. Classification of TFs based on their binding properties. Graphical 
representation of: (a) what type of TF each class includes and (b) what are the binding properties of each class and how each class 
affects chromatin after binding. AIFs bind open or dense chromatin without preference, but when nucleosomes are bound, they are 
displaced. ADFs bind open chromatin only and no changes are observed post binding. Finally, IDFs bind chromatin in three different 
scenarios: (i) IDF binds dense chromatin and maintains it (no changes are observed); (ii) IDF binds dense chromatin and reinforces it, 
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Table 1. Summary of most of the predicted/validated pioneer factors in humans in the literature. The table has been expanded 
from the one published by Iwafuchi-Doi and Zaret in 2014. 
 
TF name Predicted/validated pioneering activity Reference 
FoxA Inducing transdifferentiation Huang et al. 2011; Sekiya and Suzuki 2011 
 Establishment of the competence for liver development Lee et al. 2005 
 Occupying silent liver enhancer in endoderm progenitors Gualdi et al. 1996 
 Recruitment of histone variant H2A.Z Updike and Mango 2006 
 Chromatin decompaction Fakhouri et al. 2010 
 Binding to mitotic chromatin Caravaca et al. 2013 
 Recruitment of hormone receptor Zaret and Carroll 2011; Jozwik and Carroll 2012 
 Binding to mononucleosomes, dinucleosomes, and nucleosome array 
independent of other factors in vitro 
Cirillo and Zaret 1999; Cirillo et al. 2002 
 Increasing DNA accessibility in compacted nucleosome array independent of 
other factors in vitro 
Cirillo and Zaret 1999; Cirillo et al. 2002 
Oct3/4 
Pou5f3 
Inducing zygotic genome activation Foygel et al. 2008; Lee et al. 2013 
 Binding to target sites before zygotic genome activation Leichsenring et al. 2013 
 Inducing reprogramming Takahashi and Yamanaka 2006 
 Binding to chromatin that is not DNase-sensitive and not premarked by 
common histone modifications in vivo 
Soufi et al. 2012 
Sox2 Inducing zygotic genome activation Pan and Schultz 2011; Lee et al. 2013 
 Inducing reprogramming Takahashi and Yamanaka 2006 
 Binding to chromatin that is nonhypersensitive and not premarked by 
common histone modifications in vivo 
Soufi et al. 2012 
 Inducing tumor formation Bass et al. 2009; Boumahdi et al. 2014 
Klf4 Inducing reprogramming Takahashi and Yamanaka 2006 
 Binding to chromatin that is nonhypersensitive and not premarked by 
common histone modifications in vivo 
Soufi et al. 2012 
Ascl1 Inducing transdifferentiation Vierbuchen et al. 2010 
 Binding to nonhypersensitive chromatin in vivo Caiazzo et al. 2011; Son et al. 2011; Wapinski et al. 2013 
Pax7 Establishment of the competence for melanotrope development Budry et al. 2012; Drouin 2014 
 Increasing DNA accessibility in native chromatin Budry et al. 2012; Drouin 2014 
PU.1 Inducing transdifferentiation Feng et al. 2008 
 Increasing DNA accessibility in native chromatin Ghisletti et al. 2010; Heinz et al. 2010; Barozzi et al. 2014 
GATA4 Inducing transdifferentiation Huang et al. 2011 
 Occupying silent liver enhancer in endoderm progenitors Bossard and Zaret 1998 
 Recruitment of hormone receptor Zaret and Carroll 2011; Jozwik and Carroll 2012 
 Binding to nucleosome array independent of other factors in vitro (not as 
effective as FoxA) 
Cirillo et al. 2002 
 Increasing DNA accessibility in compacted nucleosome array independent of 
other factors in vitro (not as effective as FoxA 
Cirillo et al. 2002 
GATA1 Binding to mitotic chromatin Kadauke et al. 2012 
CLOCK:BMAL1 Increasing DNA accessibility in native chromatin Menet et al. 2014 
P53 Increasing DNA accessibility in native chromatin Laptenko et al. 2011 
 Binding to chromatin that encodes high intrinsic nucleosome occupancy Lidor Nili et al. 2010 
 Binding to nucleosome independent of other factors in vitro Espinosa and Emerson 2001 
 Recruitment of histone acetyltransferase p300 Espinosa and Emerson 2001 
MyoD Structure organizer of 3D genome architecture in muscle cells Chen et al. 2020 
Pbx1 Skeletal muscle lineage specification Berkes et al.,  Maves et al.; Magnani et al.; Thiaville et 
al.  Grebbin et al.  
 Breast cancer (regulation of the estrogen response) Berkes et al.,  Maves et al.; Magnani et al.; Thiaville et 
al.  Grebbin et al.  
 Adult neurogenesis and neuronal lineage specification Berkes et al.,  Maves et al.; Magnani et al.; Thiaville et 
al.  Grebbin et al.  
Gro/TLE/Grg Meditate embryonic segmentation, dorsal-ventral patterning, neurogenesis, 
and Notch and Wnt signaling 
Sekiya and Zaret, 2007 
AP-1 Nucleosome displacement at enhancers in murine mammary epithelial cells Atak et al., 2021 
CREB1 Induces transcription of genes in response to hormonal stimulation of the 
cAMP pathway 






5.3 Tools and models to investigate this relationship: experimental and 
computational methods are complementary 
 
To this day, the most used experimental technique that has been developed to study protein:DNA 
interactions is chromatin immunoprecipitation followed by sequencing (ChIP-seq) (Landt et al., 
2012). ChIP-seq techniques use Next Generation Sequencing to map proteins’ binding sites within 
the genome (Barski and Zhao, 2009), and are used to assess whether TF-specific binding sites are 
occupied (Héberlé and Bardet, 2019). When a genomic area is identified to be enriched in the 
number of aligned reads for a specific TF, those enriched regions represent the likely locations of 
where that TF interacts with the DNA. By overlapping the ChIP-seq peaks with genomic regions of 
different DNA accessibility (i.e. open VS dense chromatin, methylated VS unmethylated DNA), one 
could pinpoint where those TFs are bound in the genome and therefore classify that TF based on its 
binding properties. For instance, if a TF has bound to inaccessible DNA, it could be a potential IDF, 
as the steady state of the cell showed that the chromatin was kept dense post TF binding. If it is the 
other way around and the TF is found in open chromatin, one would not know if the TF had opened 
the chromatin (like an AIF would do) or had just bound there because the chromatin was already 
accessible (like an ADF, as its binding is restricted to certain areas of open DNA). Experimentally, 
potential pioneers can be validated by TF overexpression analysis to observe gain in accessibility in 
areas of increased binding (Iwafuchi-Doi and Zaret, 2014). These experimental techniques therefore 
allow to come to conclusions to certain extents; however they also present limitations such as 
difficulties to adapt for high-throughput screening (Park, 2009). For example, just by looking at the 
overlaps from the raw data (e.g. intersecting ChIP-seq with ATAC-seq to know where peaks are 
found within the genome) one would not necessarily understand the relationship and the 
information on the behaviour of that TF. Hence why the need to use computational methods too. 
 
Areas of enrichment can also be identified computationally using methods such as peak calling 
(Taleb et al., 2019), which rely on algorithms capable of defining sites of protein:DNA binding. For 
my project I will be using a Bioconductor package called ChIPanalyser which algorithm is based on a 
statistical thermodynamic framework. The field of statistical thermodynamics is the study of how 
one can organize all the different combinations of particles in a system. ChIPanalyser, available on 
Bioconductor as an R package, models and predicts the binding of TFs to the DNA (Zabet and Adryan, 
2015; Gentleman et al., 2015; Martin and Zabet, 2020). The question that ChIPanalyser aims to 
answer is “what describes the probability of a specific DNA region to be bound by a TF?”. 
ChIPanalyser will output ChIP-seq-like profiles based on: 
 
(i) a Position Weight Matrix (PWM) which is a representation of patterns in a biological 
sequence, called motif, which TFs will preferentially bind to. This informs the model how 
likely the protein is to bind at a specific genomic sequence. A PWM will indicate, for each 
base pair, how likely this motif is going to show a binding event. One issue associated to 
models which solely rely on PWMs as markers for TF:DNA binding is that there are more 
motifs that fit the high probability of having a binding event than actual binding events. 
Therefore, it is necessary to understand what other factors contribute to TF binding; 
 
(ii) the number of molecules bound to the DNA indicated by the letter N. It states how many 
TFs are bound to the DNA, on average, at any time point. TFs can also unbind; ChIPanalyser 





(iii) a scaling factor, which is a modulator for the binding specificity indicated by the symbol λ. 
This controls how well a TF can discriminate between high and low affinity binding sites. 
High values for λ translate into poorer ability for the TFs to discriminate between high and 
low affinity sites (Martin and Zabet, 2020); 
 
(iv) DNA-accessibility of that specific site, which indicates whether chromatin is compacted or 
not.  
 
Equal weight of importance is given to these four parameters. The established relationship between 
these four parameters allows to come to conclusions regarding TF binding patterns: if the prediction 
is accurate, those parameters are sufficient to explain the relationship between that TF and DNA. 
On the other hand, if the model fails to predict TF:DNA binding mechanisms, that is a sign that there 
is something else that needs to be taken into account, and those parameters are not sufficient to 
explain the binding event. ChIPanalyser therefore, models TF binding based on real ChIP-seq data 
and provides a predictive tool to extract features of the TF binding mechanisms, eventually allowing 
to discriminate between TFs that show different binding properties and therefore to shortlist 
potential AIFs. With partial experimental data ChIPanalyser can show where to expect TF binding 
events and allows to highlight what the main force that drives binding is. For example, is TF binding 
dependent upon whether chromatin is accessible, or does it depend on the number of TFs bound 
to that stretch of DNA? To summarise, when one overlaps ChIP peaks with DNA accessibility for both 
accessibility dependent and independent factors, it will be clear that they both will bind to accessible 
DNA, but while classical TFs bind only in open chromatin, accessibility independent TFs bind in dense 
chromatin and open it (Lamparter et al., 2017). There are two possibilities to distinguish between 
the two: one experimental and one computational. Both wet and dry lab approaches allow to come 
to these conclusions: as a matter of fact, computational and experimental designs are 
complementary (Ding et al., 2010). 
 
5.5 Chromatin accessibility  
Computational and experimental models which determine the interactions between DNA and TFs 
require incorporation of DNA accessibility measures. There are several methods that can be used to 
map DNA accessibility, including ATAC-seq, DNAse-seq, MNase-seq and NOMe-seq. ATAC-seq 
(Assay for Transposase Accessible Chromatin using Sequencing) works by probing DNA transposases 
to DNA sequences at a genome-wide level. The transposases will insert themselves into open 
chromatin rather than dense chromatin, which translates into higher gene expression because more 
TFs can bind to the DNA sites. The outputted reads reflect genomic accessible regions that 
correspond to lack of nucleosomes, therefore map the chromatin accessibility landscape at a 
genome-wide level (Sun et al., 2019). 
 
Identification of active gene regulatory elements can also be assayed via DNase-seq, which stands 
for DNase I hypersensitive sites sequencing (Song and Crawford, 2010). DNase-seq is a high-
resolution technique to map active gene regulatory elements genome-wide, and is therefore a 
useful tool to identify promoters, enhancers and other regulatory regions. DNase-seq uses the 
restriction enzyme DNase I to selectively digest accessible DNA regions. Instead, the regions where 
chromatin is inaccessible are not digested. By capturing and sequencing in high throughput the 
DNase-digested fragments across the whole genome, DNase-seq allows to identify the most active 




MNase-seq, short for Micrococcal Nuclease digestion with deep sequencing, is another technique 
used to assay chromatin accessibility. MNase-seq is used as probe of DNA sequence organization 
and chromatin structure (Keene, 1981). When a region of DNA is occupied by histones or other 
proteins such as TFs, MNase, which is an enzyme that digests DNA in regions that are not stably 
bound by proteins (Cuatrecasas et al.,1967), is unable to bind to the DNA. The sequenced fragments 
output nucleosome location information, therefore revealing structural information about 
chromatin. In this case absence of nucleosomes denotes accessible regions, whilst presence of 
nucleosomes indicates dense chromatin. MNase-seq was used by Teif et al. in 2012 to map 
nucleosome positions by genome-wide sequencing of nucleosomal DNA from mouse embryonic 
stem cells, neural progenitor cells and mouse embryonic fibroblasts after digesting the linker DNA 
between nucleosomes with MNase. They observed that pluripotency master regulators such as 
Sox2, Oct4 and Nanog as well as chromatin remodelers Chd7 and Brg1 preferentially bound to DNA 
regions that coincided with well-positioned nucleosomes. They concluded that these factors had 
pioneering properties as they could efficiently bind while the DNA target site interacted with a 
histone octamer (Teif et al., 2012). According to these findings, from the MNase-seq data it can be 
concluded that a factor displays pioneering properties as its peaks coincide with nucleosomes. 
However, this approach would not allow to distinguish between TFs that bind nucleosomes and 
displace them, like AIFs, and TFs that bind nucleosomes and maintain or even reinforce the closed 
chromatin state, like IDFs. 
 
The last technique to assay chromatin accessibility that I will discuss is NOMe-seq. Short for 
Nucleosome Occupancy and Methylome sequencing, NOMe-seq measures the relationship 
between DNA methylation and nucleosome occupancy and generates a map of these two signals 
showing how these epigenetic components correlate with each other (Lay et al., 2017). The genome 
is engineered to introduce a GpC methyltransferase enzyme that artificially methylates GpC 
dinucleotides that are not protected by nucleosomes or protein binding sites, i.e. everything that is 
accessible. In order to measure the increase in accessibility, the methylation level is measured, and 
it is found that everything that gained methylation was accessible for the methyltransferase enzyme 
to add methylation (NOMe-Seq - Nucleosome Occupancy and Methylome Sequencing, 2021).  
 
5.6 Why using ChIPanalyser  
What ChIPanalyser adds to the equation is that once the model has been trained with different 
scenarios (e.g. varying the DNA accessibility percentage), one can better dissect what happens to 
proteins:DNA interaction. Instead, by just studying the overlaps of the experimental data, we could 
be missing out additional insights that led to that final result (perhaps the presence of a co-factor of 
a pioneer TF that previously made chromatin accessible). Metaphorically, this is like the “chicken 
and the egg” problem: if one observes a TF binding open chromatin, it will not be possible to know 
whether it was that TF’s presence that had opened the chromatin, or if that genomic area was 
already accessible for TFs to bind – which is why the presence of co-factors is not to exclude. By 
calculating TF binding based on a biophysical model, one can filter out potential AIFs. Using 
ChIPanalyser is therefore complementary to running ChIP-seq experiments, and will still answer 
questions such as “is that specific TF bound in that specific region (e.g. open chromatin), because it 
is restricted to binding to certain regions only, or could that same TF bind to other areas as well (e.g. 
dense chromatin), maybe because DNA accessibility does not affect its binding?”. In that case, a TF 
might be found in open chromatin according to experimental data following ChIP-seq, but that 
chromatin, which is now accessible, might have been opened by a cofactor or a different TF which 
could be the real pioneer TF. This means that that specific TF is a traditional one, which is normally 
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affected by DNA accessibility levels, whilst the TF that had previously made chromatin open is an 
accessibility independent factor. At the same time, one cannot just look at the binding motifs and 
take for granted that motif equals binding event, because there are many more motifs than there 
are actual binding events. For example, some sites are concentration-dependent and, simply, there 
might not be enough of a TF to bind every single motif.  
 
In conclusion, in order to run ChIPanalyser one still needs experimental data for ChIP-seq, as well as 
some measure of DNA accessibility like ATAC-seq or DNase-seq (even DNA methylation can be used, 
when taken in the context of its correlation with closed chromatin in many cases). However, 
experimentally one cannot easily tweak these parameters. For instance, binding in accessible 
chromatin does not mean that the TF cannot bind dense chromatin too, and this can be explored 
with ChIPanalyser by varying the percentage of accessible genome and studying the binding pattern. 
In two cases there will not be peaks in dense chromatin: either the TF has pioneering properties, 
which means whatever site wes there has been opened, or there are binding sites, but the TF does 
not have pioneering properties, and the binding sites are masked by dense chromatin. Testing 
different hypothesis allows dissecting the binding properties of different TFs and classifying them 
based on their properties. 
5.7 Aims of project 
Previous analyses within Dr. Zabet’s laboratory included D. melanogaster, M. Musculus and H. 
sapiens genomes studies. Several TFs from human and mouse cell lines have already been 
characterised, thereby TF classification into different groups based on their chromatin accessibility 
preference has been possible. As a result of these analyses, 48 potential AIFs, including known 
pioneers such as CTCF and MYC, have been identified. These results suggest that there might be 
more pioneers and co-factors of pioneers than it had been previously hypothesised, in human and 
mouse data. I will be using ChIPanalyser on human ChIP-seq data hoping to further classify TF 
binding properties using different metrics to assess DNA accessibility. It will be interesting to not 
only shed light on newly discovered potential AIFs, IDFs and other TF classes, but also to compare 
those results with similar mouse genome-wide studies. The overarching aim of the project will 
therefore be to have a comprehensive view of TF binding models in mammalian systems and to 
shortlist potential AIFs in mammalian cell lines. The main question that this project aims to tackle 
is: can ChIPanalyser, in conjunction with ChIP-seq data and several methods to map DNA 
accessibility, allow us to identify whether TFs display pioneering functions? And therefore, are there 
different mechanisms for the binding of TFs? I.e. do all classes bind similarly to the DNA, regardless 
of their ability to bind to euchromatin vs heterochromatin? Fig. 3 shows ChIPanalyser’s workflow in 
a nutshell. 
 
The novel aspects compared to previous analyses are: 
 
(i) comparing the impact of different DNA accessibility measures to see if results are 
consistent. These include DNase, ATAC-seq, MNase-seq and NOMe-seq (Meyer and Liu, 
2014); 
 
(ii) instead of scaling the data within known genomic regions (e.g. 10 to 60, i.e. the stronger-
bound regions), it could be interesting to check how scalable this is by taking 50 medium-
bound regions (e.g. 500 to 550) and 50 weak-bound regions (regions that have lower 
levels of binding, e.g. 1000 to 1050) to understand how well the weaker-bound regions 
perform. The training set is made of the regions at the top where the ratio between true 
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positive and true negative signals is balanced. Validating on the training set would yield 
a biased optimal model fit as those regions were used to teach the model what to 
predict. In fact, it is known that biophysical models perform better for stronger bound 
regions (Kaplan et al., 2011), but the regions displaying weaker binding will be used to 
validate the model which will have been previously trained on the top 10 regions. 
Checking validation on the weaker-bound regions too is important because by doing so 
one can understand whether a TF can still bind to DNA without taking into account DNA 
accessibility; this is so that we can also understand the Biology behind TF binding – does 
a TF display pioneering properties only at strong sites, or is it capable to open chromatin 
at weaker-bound ones too? – other than testing the reliability and the accuracy of the 
model.  
 
ChIPanalyser cannot be trained on weaker-bound regions as the ChIP-seq data presents 
so many true negatives (regions that are not bound), that if the model was trained on 
poor quality data it would predict everything as negative. There would not be enough 
peaks on the training dataset for the model to learn the real TF’s binding patterns, thus 
the model would behave as if predicting no peaks would always be accurate. Since this 
study is conducted genome wide, selecting the top 10 regions on a chromosome 
translates into the fact that, when taking the whole genome into account, the top 10 
regions of each chromosome will be within the top 50 or 60 regions genome wide (i.e. of 
all chromosomes).  
 
 
Figure 3: ChIPanalyser workflow in a nutshell. The input data include DNA accessibility and ChIP-seq data; the output data are the 
optimal parameters of binding from which the TF:DNA predicted binding profiles can be plotted (left), and the TF:DNA binding 






6.1 Data pre-processing 
 
The project’s pipeline starts with the data pre-processing. Raw human ChIP-seq fastq datasets for 
all the TFs available in the IMR90 cell line 5 validated AIFs in the literature from IMR90 and HepG2 
cell lines were downloaded from ENCODE release 3. Raw human chromatin accessibility fastq 
datasets for IMR90 and HepG2 (in the form of DNase-seq, MNase-seq, ATAC-seq and NOMe-seq) 
were also downloaded from ENCODE release 3 (Sloan et al., 2015). Quality assessment and 
improvement on these fastq datasets was run with fastqc version 0.11.7 (Andrews, 2010) and 
cutadapt version 1.18 in order to remove ILLUMINA adapters (Martin, 2011). In order to avoid 
carrying data contaminated from adapters and low-quality reads into downstream analysis, quality 
checking must be carried out. For this purpose, FastQC was used as a QC tool (Andrews, 2010), and 
was run before and after trimming with cutadapt. Then, the data was aligned to the hg38 reference 
genome downloaded from NCBI (ID: 884148 RefSeq) with bowtie2 version 2.3.4.1 (Langmead and 
Salzberg, 2012). Peaks were called with macs2 version 2.1.2 with a q-value threshold of 0.5 (Zhang 
et al., 2008). Fig. 4, below, summarises the main pre-processing steps. 
 
 
The final number of TFs in the IMR90 and HepG2 cell lines that were analysed is 20. The cell lines 
and TFs were picked based on data availability on ENCODE. The pool of TFs is small because this 
analysis has many layers of complexity, including 3 different validation regions and 4 different DNA 
accessibility assays (see 5.7 Aims of project). Table 2 includes information on each of the 20 TFs such 
as whether it does or does not bind specifically to the DNA, and what its primary role is. Fig. 5 shows 
the DNA sequence logos of the motifs of each of the 20 TFs. 
 
This data pre-processing method applies to both TFs that have a DNA sequence preference as well 
as other proteins such as the chromatin remodelers (e.g. CHD1) that, instead of binding the DNA 
specifically, bind nucleosomes, or are recruited by other DNA binding proteins. It is still unclear to 
what degree chromatin remodelers are swayed by local DNA sequences when shifting a nucleosome 
to different positions. Chromatin remodelers cluster to form complexes with other proteins: this 
interaction was reported with other sequence-specific transcriptional regulators, thereby 
facilitating gene expression (Tyagi, Imam, Verma and Patel, 2016). The PWMs of RCOR1, RAD21, 
CHD1 and SCM3 (which do not specifically bind the DNA) were constructed de novo from ChIP data 
and, thus, represent a mix of the motifs of the proteins that recruit them, although this does not 
reflect their binding to the DNA, as it is not specific. In order to check ChIPanalyser’s accuracy at 
recovering the real TF’s binding patterns, previously reported AIFs in the literature in the cell lines 
IMR90 (p53 and MyoD) and HepG2 (FoxA1, GATA4 and CREB1) were used as positive controls for 
this analysis. The only difference was that the NOMe-seq was not available for HepG2, as it was not 
possible to download this dataset. 
Merging fastq files 
with cat









Peak calling wih 
MACS2
Figure 4: workflow of the data pre-processing of all TFs and all DNA accessibility fastq single-end Illumina FASTQ files. Files 
were downloaded from ENCODE release 3 and merged using the cat function. FastQC was used before and after cutadapt to 
check the reads quality. Cutadapt was used to trim and remove adapters. To map the trimmed read sequences to the reference 




Table 2: The TFs analysed in this project are 20. Most of them specifically bind to the DNA. Raw human TF ChIP-seq datasets were 
downloaded from ENCODE release 3 for all the TFs available in the IMR90 cell line and some used as controls from IMR90 and HepG2. 
 
TF name Primary role Motif repositories Specific 
DNA 
binding 
CTCF Regulating the 3D structure of chromatin Hsapiens-jaspar2018 Yes 
CEBPB Regulation of genes involved in immune and inflammatory responses Hsapiens-jaspar2018 Yes 
MAFK Transcriptional repressors when these proteins dimerize among themselves Hsapiens-jaspar2018 Yes 
BHLHE40 Control of circadian rhythm and cell differentiation Hsapiens-jaspar2018 Yes 
MAZ Dual roles in transcription initiation and termination Hsapiens-SwissRegulon Yes 
MXI1 Potential tumor suppressor Hsapiens-jaspar2018 Yes 
USF2 Repressors of the human MCT1 (monocarboxylate transporter 1) promoter Hsapiens-jaspar2018 Yes 
NFE2L2 Regulation of metabolism Hsapiens-jaspar2018 Yes 
FOS Regulating the development of cells destined to form and maintain the 
skeleton 
Hsapiens-jaspar2018 Yes 
RFX5 Production of specialized immune proteins called MHC class II proteins Hsapiens-jaspar2018 Yes 
ELK1 Role in neuronal functions Hsapiens-jaspar2018 Yes 
RCOR1 Determining neural cell differentiation Hsapiens-SwissRegulon No 
RAD21 Sister chromatid cohesion and separation. Subunit of cohesin, therefore does 
not have sequence preferences 
Hsapiens-SwissRegulon No 
CHD1 Alter gene expression possibly by modification of chromatin structure. 
Chromatin remodeler 
Hsapiens-SwissRegulon No 
SMC3 Central component of cohesin, thus does not have sequence preferences Hsapiens-SwissRegulon No 
P53 Key cell cycle regulator that manages the response to stress signals Hsapiens-jaspar2018 Yes 
MYOD Regulating muscle differentiation Hsapiens-jaspar2018 Yes 
GATA4 Key role in the development of the heart. It is involved in the induction of 
cardiac specific gene expression 
Hsapiens-HOCOMOCOv10 Yes 
CREB1 Plays a role in the regulation of immune responses Hsapiens-jaspar2018 Yes 
FOXA1 Acts as a pioneer factor for ER and AR allowing the nuclear receptors to make 












Figure 5: DNA sequence logos of the 














Following the pre-processing of the fastq datasets of the four DNA accessibility assays in IMR90 and 
HepG2 which are ATAC-seq, DNase-seq, MNase-seq and NOMe-seq, the DNA accessibility data were 
subset in R with a vector of quantile density accessibility (QDA) of 12 levels with a window size of 
100 base pairs (QDA: from 0 to 0.9, plus 0.95 and 0.99), where level 1 (or QDA=0) corresponds to 
0% of chromatin being dense, meaning this QDA file considers all regions of the genome as fully 
accessible, regardless of their actual accessibility, whilst level 12 (or QDA=0.99) corresponds to 1% 
of chromatin being accessible (all chromatin is dense, but the top 1% of the genome). MNase-seq 
datasets are created in a way that the less reads there are, the more accessible the DNA is. Thus, a 
QDA of 0 correspond to 100% dense DNA instead of 0%. This was considered when creating the QDA 
files, and the function was adapted in order to be able to directly compare MNase-seq with ATAC-
seq, DNase-seq and NOMe-seq. 
 
These 12 different thresholds of DNA accessibility (namely QDAs) were used to run the ChIPanalyser 
model to create AUC and MSE heatmaps, which respectively indicate: (i) the estimated number of 
bound molecules according to the model, and (ii) the model scaling factors, from which the optimal 
values can be selected. The closer the AUC is to 1, the better the model is estimating the ChIP-seq- 
like profile. The accessibility percentage per each QDA for all four methods was calculated in R. 
Finally, motifs for each TFs are obtained in R using the MotifDb package (Shannon and Richards, 
2020), under the form of PWMs, by running a function that queried various motif databases. All 
PWMs were downloaded from the database Jaspar2018 (Ge Tan, 2017). If the motif for a TF was not 
available, several other databases including SwissRegulon and HOCOMOCO v10 were scanned for 
the motif, however if the motif was not available, the TF would have been removed from the 
analysis. 
 
The rationale behind using many QDA values to fit the model is to assess how the various TFs 
perform under different DNA accessibility levels: an AIF would bind to dense chromatin as its binding 
is not restricted to accessible regions only, whereas an ADF would not be able to bind to dense 
chromatin as its binding properties stop it from reaching its target site. To assess the quality of the 
predictions, two measures are used: the area under the curve (AUC) to highlight how well the peaks 
are predicted and the mean squared error (MSE) to show how different the predicted profile is from 
the actual one. The AUC indicates the resemblance of the predicted profile compared with the 
actual ChIP data (the higher, the more accurate it is). The aim is to minimise the mean squared error 
(MSE) when comparing the prediction with actual ChIP-seq data and therefore find values that give 
the lowest error possible. If a TF displays a high AUC value even for the bottom QDAs (0.7 – 0.99), 
that would indicate that the TF can bind dense chromatin, as the prediction accuracy was high even 
when most of the regions were considered inaccessible by the model (a QDA of 0.99 corresponds 
to 99% dense regions). 
 
Instead, if the only AUCs to be high are the top ones (0.0 – 0.4), this would suggest that the TF binds 
open chromatin only, as a low QDA corresponds to mostly accessible chromatin (Martin and Zabet, 
2020). Therefore the question is “how do different DNA accessibility levels affect TF binding?” The 
hypothesis is that, if no changes are observed in the AUC when the percentage of accessible genome 








6.2 ChIPanalyser experimental design 
 
ChIPanalyser (Martin and Zabet, 2020) is an R package available on Bioconductor that can reproduce 
ChIP-seq-like profiles based real ChIP-seq data and therefore is able to model and predict TF:DNA 
binding, by computing the probability that a binding site is occupied, therefore circumventing costly 
ChIP-seq experiments. ChIPanalyser version 1.12.0 was run several times on the aforementioned 
TFs: per each DNA accessibility level (1 to 12), per each DNA accessibility measure (ATAC-seq, 
DNase-seq, MNase-seq, NOMe-seq), per each TF (total 20, see table 2) and per each validation 
region (strong, medium and weak-bound). The model was trained on the top 10 regions and 
validated on different sets of regions – 50 strong, 50 weak and 50 medium-bound regions. The AUCs 
reported in this thesis are those always belonging to the validation datasets, and never the training 
datasets. The strong and medium-bound validation region ranges are constant, but the weaker-
bound regions varied according to how many real ChIP-seq peaks a TF presented. Therefore in order 
to decide which regions range to use as weak, the number of ChIP-seq peaks was divided by 3 and 
the first 50 regions of the bottom third were used for validation (see table 3). Note that the number 
of ChIP-seq peaks of ELK1 was only 145, therefore this TF was only validated on the top regions. 
 
Table 4, below, recapitulates what each parameter mean. Different values for λ and N were tested 
to evaluate how well the predicted ChIP profiles resembled the actual ChIP-seq data. To assess the 
quality of the predictions, two measures were used: AUC to highlight how well the peaks are 
predicted and MSE to show how different the predicted profile is from the actual one. The 
ChIPanalyser experimental design includes extracting ChIP-scores at the loci of interest, training and 
validation of the data and finally computing the optimal parameters. Hg38 was downloaded from 
NCBI and used as the reference genome. One example line is found below (see table 4 for a 
description of each argument).  
TFs Total ChIP-seq peaks number Top regions range Middle regions range Bottom regions range 
CEBPB 227924 11-60 500-550 18620 – 18670 
MAFK 111711 11-60 500-550 18620- 18670 
RAD21 87317 11-60 500-550 14550- 14600 
BHLHE40 65406 11-60 500-550 10900-10950 
FOS 62082 11-60 500-550 10350-10400 
SMC3 58914 11-60 500-550 9820-9870 
MAZ 57739 11-60 500-550 9630-9680 
CTCF 56686 11-60 500-550 9450-9500 
RCOR1 55700 11-60 500-550 9290-9340 
MXI1 46379 11-60 500-550 7730-7780 
USF2 40012 11-60 500-550 6670-6720 
NFE2L2 34719 11-60 500-550 5790-5840 
CHD1 27160 11-60 500-550 4530-4580 
RFX5 5461 11-60 500-550 910-960 
ELK1 145 11-60 NA NA 
p53 9968 11-60 500-550 6645-6695 
MYOD 5190 11-60 500-550 700-750 
CREB1 205936 11-60 500-550 46940-46990 
FOXA1 205372 11-60 500-550 46940-46990 
GATA4 36300 11-60 500-550 12610-12660 
Table 3: Number of real ChIP-seq peaks for each TF in IMR90 and HepG2 cell lines and their validation regions. The range for strong and 
medium-bound regions is fixed. The weaker-bound regions are chosen by dividing the total number of peaks by 3 and multiplying by 2. The 
weak-bound range is then obtained by taking the top 50 regions. E.g.: total number of peaks=3000. 3000/3 x 2 = 2000. Weak-bound validation 
range: 2000–2050. Sometimes, the first 50 regions of about half the number of peaks of each TF were used instead. The results were consistent. 




qsub -cwd -j y -q all.q \                        #Standard for qsub jobs in Bash 
-o ./CTCF_12.txt \                               #Name of output file 
-b y -N CTCF_12 \                                #Name of job on the cluster 
Rscript ./ChIPanalyser_general.R \                #Name of the R script to execute 
CTCF 12 IMR90 1 10 11 60 topRegions DNase        #The 9 fundamental arguments 
 
Once the model had been validated on each region and the optimal binding parameters per each 
specific TF, with that specific DNA accessibility measure and QDA, had been estimated, the next step 
was to plot. Fig. 6 summarises ChIPanalyser’s main steps. 
 
 
Table 4: Summary of which parameters and arguments were used to execute ChIPanalyser on the 20 TFs in the cell line IMR90 and 
HepG2, with a brief description of what they are used for. If not specified, then the parameters were left as default. ChIPanalyser 
was run in R v3.6.0 as qsub jobs submitted in Bash. 
 
Parameters/Arguments Value Description 
TF See table 2 for a 
complete list 
The TF we are studying. 
QDA From 0 to 0.9, plus 0.95 
and 0.99 
Used to assess how the TF performs under different DNA accessibility 
thresholds. 
Cell line IMR90 or HepG2 The cell line of interest. 
Regions for model training  1-10 Range of genomic regions used to train the model. 
Regions for model 
validation 
See table 3 for a 
complete list  
Range of genomic regions used to validate the model. 
Validation regions Either strong, medium 
or weak-bound 
Used to check if a TF displays pioneering properties at stronger-bound sites 
only or not. 
DNA accessibility assay Dnase-seq, ATAC-seq, 
Mnase-seq, NOMe-seq 
The DNA accessibility method used. 
lociWidth 50000 When no loci are provided, ChIPanalyser will split ChIP data into bins of width 
equals to lociWidth. 
Noise filtering method Sigmoid Noise filter applied to ChIP data (could be zero, mean, median or sigmoid). 
Sigmoid applies a logistic weighting to every score, modulating ChIP scores 
around the 95th quantile point. 
stepSize 100 Used to restrict the size of the ChIP-seq-like profile produced 
by computeChIPProfile. Instead of returning ChIP-seq like score for each base 
pair, this will return the predicted enrichment score for every “n” base pairs. 
chipSd 150 Standard deviation of peak width. SD of peak width is used during the 
smoothing of ChIP data. 
chipMean 150 Average ChIP peak width. Peak width is used during the smoothing of ChIP 
data. 
Range of N From 1 to 1e+08 Possible number of bound molecules (positive numeric value). 
Range of λ Between 0.25 and 5 
with an interval of 0.25 
Possible lambda values (positive numeric value). 
DNA sequence set hg38 Reference genome. 
Load files after pre-




Run ChIPanalyser on 
training regions
Validate and infer 
optimal parameters
Plot heatmaps and 
ChIP-seq-like profiles
Figure 6: training and validating ChIPanalyser experimental design. The model was trained on the top 10 regions and validated on other 
sets of regions. The workflow includes use of the previously pre-processed data, as well as the creation of a few objects, such as PWMs, 
DNA sequence of the reference genome, DNA-accessibility, as well as GRange objects containing ChIP-seq data. The function processingChIP 
was run to extract ChIP-scores at the loci of interest. Training and validation of the data was completed before moving onto computing the 
optimal parameters with computeOptimal function. Finally, heatmaps were plotted, optimal parameters extrapolated, and ChIP-seq-like 






6.3 Plotting and estimating optimal parameters 
 
To allow estimation of the optimal combination of parameters, thereby allowing selection of λ and 
N, heatmaps of 12 different metrics including MSE and AUC (Martin and Zabet, 2020) were plotted 
with the plotOptimalHeatmaps function.  ChIP-seq-like profiles for validation were plotted with the 
plotOccupancyProfile function, armed with values for number of bound molecules (N) and the PWM 
scaling factor (λ) obtained by indexing. Other than plotting the heatmaps for training and profiles 
for validation, another method of data visualisation, which is TF clustering, was applied. For this, the 
optimal AUC from the validated datasets was used. Clusters of TFs were made based on their 
accessibility preference profile using the k-means clustering method. In order to perform it, the data 
obtained from the ChIPanalyser step was merged with pre-existing data that had been obtained 
within Dr. Zabet’s lab in previous years (Pop R., 2021). This step was necessary in order to have 
enough data to be able to cluster accurately.  
 
K-means clustering works with an algorithm that allows to cluster data of the same nature in k 
groups, in order to find patterns within the data. An elbow plot (fig. 8) was generated from which 
the number of optimal k clusters to use was selected (this will be where the curve plateaus and will 
indicate how many groups there are in the given datasets). In this case, k=5 was selected, and the 
five groups were labelled as AIF, partial AIF, ADF, poorly predicted and IDF based on their trends. 
These plots will be called QDA-means plots in the results section and will show the QDA on the x-
axis and the optimal AUC on the y-axis. The clustering results were plotted as classification 
heatmaps, where each colour corresponded to a class of TFs. 
 
To interpret the results, there are 5 possible scenarios. The criteria taken into account are whether 
there is low (<0.8) or high (>0.8) binding in: areas of open chromatin, areas of dense chromatin, and 
if the difference between the AUC in dense vs open chromatin was high or low. The 5 classes are 
AIF, partial AIF, ADF, poorly predicted and IDF. Fig. 7 gives a full explanation of how to interpret the 
results from the k-means clustering algorithm. 
 






Figure 7: graphical illustration of the results interpretation behind the k-means algorithm. The low-end QDAs are 0 – 0.2 and high-
end QDAs are 0.8 – 0.99. The slopes on the left indicate what a QDA plot would look like for each TF class (QDA on x-axis and optimal 
AUC on y-axis). Depending on the predicted AUC value in dense and open chromatin as well as the difference between these two 
values, a TF is classified as: i) AIF when AUC >= 0.8 in dense and open chromatin, and therefore AUC(dense) – AUC(open) < 0.2; ii) 
partial AIF when AUC < 0.8 in dense chromatin and >= 0.8 in open chromatin, but AUC(dense) – AUC(open) is still < 0.2; (iii) ADF when 
AUC < 0.8 in dense chromatin and >= 0.8 in open chromatin, and therefore AUC(dense) – AUC(open) >= 0.2; (iv) poorly predicted 
when AUC < 0.8 in dense and open chromatin, and the difference can either be low or high; and (v) IDF when AUC >= 0.8 in dense 
chromatin and AUC < 0.8 in open chromatin, and the difference can be either low or high. The difference column indicates the TF’s 







Figure 8: elbow plot showing how many groups there are in a 
given dataset. The k-means algorithm was run with k values 
between 1-15. The within-cluster sum of squared errors for each k 
was plotted in order to generate the elbow plot below. The lowest 
point before the “elbow” of the plot (where the line points stop 
going down drastically and start to plateau) is indicating the 
optimal number of clusters for a given dataset. Based on this elbow 







7.1 Pre-processing of TF binding datasets 
 
A significant increase in sequence quality was shown after pre-processing the data with FastQC and 
cutadapt. Per Sequence Quality Scores modules showed that all sequences had an optimal quality 
score at around 37 Phred or above, which is a measure of the probability of a sequencing error. The 
Adapter content modules showed adapter contamination which, after trimming, was at its lowest. 
The use of Bowtie2 allowed to align the sequence reads to the reference genome (hg38) and 
resulted in high alignment rates in all datasets. As a matter of fact, the overall alignment rate was 
over 90% for all TFs (highest: CEBPB with 97.91%; lowest: MXI1 with 92.55%), as shown in fig. 9, 
meaning the data was of good quality. Following alignment with Bowtie2, peaks were called with 
macs2 in order to identify the TF binding sites. The number of peaks was variable, going from the 
highest value of ~228,000 peaks for CEBPB to 145 peaks for ELK1 (fig. 10); such variation comes from 
the different expression and binding strength of each TF within the cell line. When a TF presented 






Figure 9 (left): the percentage alignment to the reference genome (hg38) of the pre-processed fastq datasets, following Bowtie, is 
very high. A good alignment of the mapped reads to the reference genome suggests that the data is reliable. When mapped, the 
reads are assigned to a specific location in the genome (highest: CEBPB with 97.91%; lowest: MXI1 with 92.55%). Figure 10 (right): 
logged number of ChIP-seq peaks after macs2 peak calling function in the IMR90 cell line. The real (not logged) number of total 
peaks is found below. Note that ELK1 only presents 145 peaks, meaning it will be only validated on the top regions. 
 
Fig. 11 shows the percentage of accessibility to which each QDA level corresponds for the four DNA 
accessibility assays used to run ChIPanalyser in this analysis, for both cell lines IMR90 and HepG2. 
As can be observed from the figure, the trends of accessibility percentages do differ between the 
four methods. The variability comes from the fact that these are different methods of measuring 
DNA accessibility. Note that whilst ATAC-seq, DNase-seq and MNase-seq follow the same 
accessibility pattern (starting at 100% accessible DNA for QDA=0 and then gradually decreasing their 
percentage of accessible genome), NOMe-seq does not follow this pattern and in this case QDA=0 
corresponds to 41% of accessible regions and QDA=0.99 corresponds to 8% accessible regions. 
MNase-seq does not go down all the way to 0%, which does not agree with the other methods used. 
Quantifying what percentage of accessible DNA corresponds to each QDA shows how some 






Figure 11: QDA threshold for each DNA accessibility measure in IMR90 (right) and HepG2 (left). It is important to quantify what is 
the percentage of accessible DNA per each DNA accessibility method in order to know which accessibility percentage corresponds to 
each QDA. The variability comes from the fact that these are different methods of measuring DNA accessibility. 
 
7.2 Preliminary evaluation of model performance 
 
Several values for N and λ were considered and heatmaps were generated plotting two metrics (AUC 
and MSE) for all combinations of those. ChIP-seq-like profiles were generated. Some TFs showed to 
be bound to the DNA regardless of the percentage of accessible chromatin, and it was also shown 
that their binding was accurately predicted by the model. For example, this was the case of CTCF, 
which activity is responsible for chromatin architecture and transcription (Luan et al., 2021). 
 
Fig. 12 shows AUC and MSE heatmaps for different DNA accessibility levels of CTCF, validated on the 
stronger-bound regions, i.e. regions with high level of binding. MSE indicates a measure of error and 
highlights how accurate the model prediction is compared to real ChIP-seq data, whilst AUC 
highlights how well the peaks are predicted. The closer the AUC is to 1, the better prediction 
ChIPanalyser is making at modelling real ChIP-seq data. Ideally, the heatmaps would pinpoint 
optimal parameters that fall into the white area for MSE (meaning the error is minimised) and purple 
for AUC. A purple colour in the AUC heatmap indicates good resemblance of the predicted profile 
compared with the actual ChIP data. The lower the λ, the higher the TF affinity for the DNA. 
 
From these observations, one can conclude that if no changes are observed in the AUC when varying 
the percentage of the accessible genome, that specific TF is insensitive to DNA accessibility, 
indicating that that TF has potential pioneering functions, and so it might be an AIF. This approach 
can address questions such as: how sensitive is this TF to DNA accessibility? ChIPanalyser predicted 
for CTCF an estimated number of bound molecules of 100,000 N (x-axis) for both AUC and MSE 
metrics, and for both accessibility levels of DNase-seq (QDA=0 corresponding to 0% dense regions 
vs QDA=0.95 corresponding to 95% dense regions). These first results are in line with a 2019 study 
where around 100,000 molecules of CTCF were found in the nucleus of human cells with some 
variation given by different cell lines and the highly diverse functions of CTCF, ranging from IDF to 
AIF (Cattoglio et al., 2019). A different study in 2019 measured that ~95% of CTCF is bound to the 
DNA (Belaghzal et al., 2019). Moreover, all N values correspond to a low λ of ~1 which indicates a 
high specificity of the TF to the DNA. Thus, from these results it seems that the percentage of 
accessible DNA does not drive the binding of CTCF, because our results show that CTCF would bind 






Figure 12: AUC and MSE heatmaps of CTCF (stronger-bound validation regions used) fitted with DNase-seq data, show the same 
number of DNA-bound molecules (x-axis) to be around 100,000, regardless of the chromatin accessibility restriction used, whether 
the QDA is 0, corresponding to 100% accessible chromatin, or 0.95, corresponding to 5% of accessible DNA. These heatmaps plot 
optimal number of bound molecules (N, on the x-axis) vs optimal scaling factor (λ, on the y-axis) and the black boxes represent the 
parameters (N and λ) pinpointed by the model to be optimal for modelling real binding. The black boxes fall into the white area for 
MSE (which means the error is minimised) and bright purple for AUC (which indicates good resemblance of the predicted profile 
compared with the actual ChIP data). The scale on the right-hand side indicates an optimal AUC of ~0.85 (the closer to 1, the better 
prediction ChIPanalyser is doing at modelling real ChIP-seq data). All values correspond to a low λ of ~1 which is promising of high 
affinity of the TF to the DNA. 
 
Similar results are observed when looking at different validation regions (fig. 13a: medium-bound 
validation regions; fig. 13b: weak-bound validation regions). This suggests that CTCF binds to the 
DNA regardless of the chromatin accessibility restrictions and regardless of the validation regions 
used, although some variation is observed due to the four different DNA accessibility assay used.  
 
(a)                                                                          (b) 
 
Figure 13: AUC and MSE heatmaps of CTCF (a – medium-bound validation regions; b – weak-bound validation regions) fitted with 
DNase-seq data, show the same number of bound molecules (N) to be around 100,000, regardless of the chromatin accessibility 
restriction used, whether the QDA is 0, corresponding to 100% accessible chromatin, or 0.95, corresponding to 5% accessible DNA. 
These heatmaps plot optimal number of bound molecules (N, on the x-axis) vs optimal scaling factor (λ, on the y-axis) and the black 
boxes represent the parameters (N and λ) pinpointed by the model to be optimal for modelling real binding. The black boxes fall into 
the white area for MSE (which means the error is minimised) and bright purple for AUC (which indicates good resemblance of the 
predicted profile compared with the actual ChIP data). The scale on the right-hand side indicates an optimal AUC of ~0.85 (the closer 
to 1, the better prediction ChIPanalyser is doing at modelling real ChIP-seq data). All values correspond to a low λ of ~1 which is 
promising of high affinity of the TF to the DNA. These results are identical to those obtained by validating the model on the stronger-




Fig. 14 shows a different TF called MAZ. MAZ (Myc-associated zinc-finger protein) is a TF with dual 
roles in transcription initiation and termination; deregulation of its expression is associated with the 
progression of pancreatic cancer (Maity et al., 2018). As fig. 14 shows, the optimal parameters for 
the MSE of this TF are actually variable, based on whether the model assumes that chromatin is 
dense, with an optimal N of between ~20,000-50,000 in accessible chromatin and of ~1,000,000 in 
dense chromatin. This suggests that this TF in particular is indeed dependent upon DNA accessibility 
levels, otherwise the predicted optimal parameters to model its binding would be equal whether 
chromatin was open or not. This is an example of a TF which does not display pioneering functions 





Figure 14: MAZ is a TF that does not display pioneering properties, as the optimal number of DNA-bound molecules (N) when 
chromatin is dense does not match the optimal N of when chromatin is accessible (optimal N of ~3,000 in accessible chromatin and 
of ~1,000,000 in dense chromatin). These heatmaps plot optimal number of bound molecules (N, on the x-axis) vs optimal scaling 
factor (λ, on the y-axis) and the black boxes represent the parameters (N and λ) pinpointed by the model to be optimal for modelling 
real binding. The black boxes fall into the white area for MSE (which means the error is minimised) and bright purple for AUC (which 
indicates good resemblance of the predicted profile compared with the actual ChIP data). The scale on the right-hand side indicates 
a poor AUC of 0 (the closer to 1, the better prediction ChIPanalyser is doing at modelling real ChIP-seq data). λ values are variable ~1 
- ~3.5 which indicates high to low affinity of the TF to the DNA, depending on the percentage of accessible DNA. 
 
The AUC and MSE heatmaps indicated good agreement between the predicted profiles and the 
actual ChIP-seq dataset. Thus, upon analysis of the heatmaps, one can infer optimal parameters to 
understand how well the model predicts TF binding by plotting occupancy profiles. To confirm that 
the model was predicting accurately ChIP profiles, we plotted the predicted ChIP-seq-like profiles 
using the optimal values for number of bound molecules – N – and the PWM scaling factor – λ. 
 
Fig. 15 shows an example of a predicted ChIP-seq-like profile from the analysis of CTCF, using DNase-
seq data and assuming all DNA is accessible. This profile shows that the model prediction is very 
accurate in both areas of open and dense chromatin, meaning that ChIPanalyser can recover the 
real ChIP-seq data with high accuracy, regardless of whether we restrict its binding to accessible 
DNA or not. Moreover, the fact that most of the background is yellow, but the peaks overlap with a 
white background, indicates that the peaks are found in open chromatin (white background = 
euchromatin) even when we make the model assume that chromatin is dense (yellow background 
= heterochromatin), which suggests that CTCF is a potential AIF: this is the steady state of the cell – 






Figure 15: ChIP-seq-like (occupancy) profile of ChIPanalyser prediction of CTCF binding in areas of 100% accessible DNA (white 
background) vs 5% accessible DNA. Yellow and white background shadings of these occupancy profiles respectively represent 
inaccessible and accessible DNA. The grey areas are real peaks, from real ChIP data. The red lines are ChIPanalyser’s predicted peaks. 
The blue lines indicate the percentage of binding site occupancy. These profiles show that the model prediction is very accurate in 
both areas of open and dense chromatin, as the red line perfectly outlines the grey peaks. If the peaks are on a white background, 
even when chromatin is assumed to be dense (profile below) that means those peaks are found in open chromatin. These are the 
same genomic regions; the only difference is that to plot the profile below ChIPanalyser was run assuming 99% of chromatin was 
dense. 
 
7.3 Analysing the general binding behaviour for the TFs 
 
For each accessibility quantile, the parameters that optimise the MSE on the training data are 
selected.  The AUC was computed and plotted for each validation set (strong, medium and weak-
bound regions) against the quantile vector, to create what will be referred to as a QDA plot (see 6. 
Methods). QDA plots show a threshold to call DNA accessibility on the x-axis, where 0 means 
everything is accessible, and 1 means chromatin is completely dense, and the AUC on the y-axis, so 
they plot DNA accessibility against the measure of quality of the prediction. If a straight line is 
plotted, it means that the TF has no preference for open or dense chromatin, independently of the 
accessibility of DNA (which is how an AIF would behave).  
 
Fig. 16 shows that ChIPanalyser has predicted several TFs to be AIFs using DNase-seq as the DNA 
accessibility measure and the strongest binding regions as validation regions. Those TFs – 
proposedly AIFs – bound with good accuracy to dense chromatin as well, as shown by the high AUC 
values averaging around 0.88, highlighting that, for them, it does not matter how stringent the DNA 
accessibility value is, the model will still predict their binding with high accuracy, as depicted by the 




Figure 16: from the pool of 20 TFs analysed in IMR90 and HepG2, ChIPanalyser has predicted 5 of them to be AIFs. This QDA plot 
plots QDA (x-axis) vs optimal AUC (y-axis) of the 20 TFs analysed, when ChIPanalyser was fitted with DNase-seq and was validated on 
the strong-bound regions. From the pool of 20 TFs, 5 of them showed pioneering-like properties and were therefore classed as AIFs, 
as shown here: when the AUC is high (equal to or above 0.8), regardless of the QDA value (0 to 1), it means that that specific TF is 
insensitive to chromatin accessibility restrictions. This is because the model had outputted an optimal AUC regardless of how dense 
chromatin was. This graph shows all of the predicted AIFs in one plot, and those are: USF2, MXI1, BHLHE40, RFX5 and CREB1. The 
thick line is the average AUC vs QDA. This is based on the k-means clustering algorithm (see Methods). To see what other kinds of 
QDA plots there are and to learn how to interpret them see fig. 7. 
 
It follows that ChIPanalyser does not predict everything as AIFs, hence why showing negative 
controls is important. Fig. 17 portrays QDA-plots where data from this analysis was bound to 
previous data in Dr. Zabet’s lab (data had to be bound due to the small sample pool in this analysis), 
where TFs were analysed in the same way but in different cell lines (K562 and HepG2) with DNase-
seq as accessibility data (Pop R., 2021). These plots show how ChIPanalyser had also predicted a 
number of partial AIFs (fig. 17a), some ADFs (fig. 17b) and some poorly predicted TFs (fig. 17c). ADFs 
have a preference for open chromatin, as shown by the abrupt slope in fig. 17b. Partial AIFS (fig. 





Figure 17: ChIPanalyser can predict several classes of TFs based on their binding properties. QDA-plots of IMR90 and HepG2 TFs 
bound to data from previous TFs in K562. These QDA plots are showing the change in AUC vs QDA for partial AIFs, ADFs and poorly 
predicted TFs. From left to right: (a) partial AIFs (straight line corresponding to high AUC but not as straight and high as AIFs (fig. 16)); 
(b) ADFs (slope from low to medium AUC); (c) poorly predicted TFs (straight line but low AUC). This graphical classification is based 
on fig. 7 – how to interpret the k-means clustering results.  
a b c 
AIFs predicted by ChIPanalyser with DNase-seq, validated on strong-bound regions 
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In order to visually summarise how ChIPanalyser classed each TF in this study, run with each DNA 
accessibility assay, per each validation region, a classification heatmap was plotted as per fig. 18, 
which sums up all the results that can be observed from individual plots into one heatmap. This is 
because different DNA accessibility measures, as well as different model validation regions, will 
influence the outcome of how a TF is classified based on its DNA binding properties. Some of these 
results are consistent: for instance, USF2 seems to behave like an AIF under all circumstances. On 
the other hand, other TFs display a different behaviour based on the parameters ChIPanalyser was 
run with. An example would be CTCF, which is predicted as an AIF throughout the whole of the 
DNase-seq, MNase-seq and NOMe-seq analysis, but it actually behaves like an IDF when 
ChIPanalyser is run with ATAC-seq. This would make sense, given its role in chromatin loops and 
TADs (Wutz et al., 2017). 
 
In every case, a decreasing pattern is observed: when the model was validated on the strong regions, 
a number of TFs were predicted as being able to bind in areas of dense chromatin, whether they 
were classified as AIFs (USF2, MXI1, BHLHE40 and more), partial AIFs (CTCF, CEBPB, FOS and more), 
or IDFs (RAD21, SMC3, MAFK and more). As the validation regions became weaker-bound, the 
prediction accuracy decreased so that, eventually, most of the TFs were classed as poorly predicted, 
except for CTCF and SMC3. This is an expected behaviour which will be explained in the discussion 
chapter of this thesis. Note that ELK1 had missing values for every medium and weak-bound 
validation region because of the low number of ChIP-seq peaks (145), which made it impossible to 
run the model on any other validation range other than the top one (11-60). 
 
The only TF that is classified by ChIPanalyser as an ADF is MAZ (ATAC-seq and DNase-seq only). 
Whilst the ADF classification is consistent in the top and medium-bound validation regions of ATAC-
seq, with DNase-seq MAZ is classified as an AIF in the top regions and as an ADF in the medium 
regions. MNase-seq and NOMe-seq, instead, classed MAZ as poorly predicted throughout the whole 
analysis. 
 
CHD1 and RCOR1 were the only two TFs which binding was classed as poorly predicted on each 
validation region and with each chromatin accessibility assay used. When ChIPanalyser was run with 
MNase-seq as chromatin accessibility assay, the prediction accuracy was at its lowest compared to 
the other three assays, and in fact there were four TFs that were poorly predicted in the top regions 
(FOS, CHD1, RCOR1 and MAZ) compared to the other methods which only had two (ATAC-seq and 
DNase-seq: CHD1, RCOR1) or three (NOMe-seq: CHD1, RCOR1 and MAZ). 
 
From the literature, p53 and MyoD are validated AIFs in IMR90. However, it seems that ChIPanalyser 
did not recover their binding properties, and in fact fig. 18 shows that ChIPanalyser classified those 
two TFs as poorly predicted. This result could be explained by other factors that are not accounted 
for by ChIPanalyser. For instance, these TFs might need the presence of co-factors for cooperative 
binding, or they might be sensitive to DNA methylation. Neither of these possibilities are considered 
by the model. Instead GATA4, FOXA1 and CREB1, which are previously reported AIFs in the HepG2 
cell line, gave different results. GATA4 was predicted as an ADF in the strong and medium-bound 
regions of ATAC-seq, and in the strong-bound regions of DNase-seq, whilst FOXA1 was predicted as 
a partial AIF in those same validation regions. Both GATA1 and FOXA1 were poorly predicted with 
the MNase-seq dataset, across all validation regions. CREB1 was predicted as an AIF in the strong 





    
 
 
   
 
 
Figure 18: ChIPanalyser’s prediction of classification of 20 TFs in the IMR90 and HepG2 cell lines, according to their DNA binding 
properties. Different DNA accessibility measures as well as different model validation regions will influence the outcome of how a TF 
is classified based on its DNA binding properties. Some of these results are consistent, such as USF2 which seems to behave like an 
AIF under all circumstances, whereas other TFs display a different behaviour based on the parameters ChIPanalyser was run with, 
such as CTCF which is predicted as an AIF throughout the whole of the DNase-seq, MNase-seq and NOMe-seq analysis, but it actually 
behaves like an IDF when the analysis is run with ATAC-seq. P53 and MYOD are the validated AIFs used as controls in IMR90 and 





8 Discussion, conclusions, and further work 
 
8.1 Research purpose and scope of the analysis 
 
Binding sites (whether they are proximal, distant or there are clusters of them) are genomic regions 
where TFs bind in order to regulate the process of transcription or, in other words, promote or 
repress gene expression (Inukai et al., 2019). ChIP-seq techniques are widely used to study 
protein:DNA interactions in order to observe molecular regions and pinpoint where are TFs bound 
in the genome (Nakato and Sakata, 2020). ChIPanalyser is an R/Bioconductor package that models 
and predicts the binding of TFs to the DNA, and outputs ChIP-seq-like profiles based on (i) DNA-
accessibility threshold to model binding site accessibility, (ii) a Position Weight Matrix (PWM – a 
representation of patterns in a biological sequence which TFs will preferentially bind to), (iii) the 
number of bound TFs to the DNA (represented by the letter N) and (iv) a modulator for the binding 
specificity (represented by the letter λ) (Martin and Zabet, 2020 and Zabet and Adryan, 2015). In 
short, starting from a DNA sequence binding motif, DNA accessibility (e.g. ATAC-seq or DNase-seq 
etc.) and ChIP data, one can infer the specificity of the DNA-bound TFs. 
 
The research scope of this dissertation was to classify TFs based on their DNA binding properties 
using ChIPanalyser. The three different classes of TFs were described as follows: AIFs have 
pioneering-like properties and can bind chromatin regardless of its accessibility constrictions, to 
then subsequently relax it and make it accessible for ADFs which, instead, can only bind already 
accessible chromatin. The third and last class includes IDFs, which will preferentially bind dense 
chromatin to then maintain and/or reinforce the compacted status. Classifying TFs aims to tackle a 
tough question in the Genomics field as TFs are at the very heart of every single cellular process. 
Learning about their properties can benefit the Genomic world beyond the simple application of 
expanding our state of the art Biological know-how, but will also offer a solid and analytical base to 
tackle more complex questions and gain a better understanding into the chain of events that lead 
to certain diseases, to then be able to target and inhibit specific cellular pathways for therapeutic 
approaches. 
 
8.2 Our main findings 
  
According to our study, the shortlisted AIFs (and partial AIFs) in the strong-bound regions of ATAC-
seq, DNase-seq, MNase-seq and NOMe-seq are USF2, MXI1, CEBPB, BHLHE40, FOS and RFX5. Those 
TFs could be responsible for opening the chromatin at their strongest sites. Two cohesion subunits 
(RAD21 and SMC3) and MAFK have been classified as inaccessibility-dependent factors, suggesting 
they prefer partially closed chromatin. CTCF was classified as either an accessibility-independent 
factor or inaccessibility-dependent factors. This indicates that CTCF could be either a pioneer or an 
insulator, and both roles have previously been proposed for this TF in the literature. 
 
Since ChIPanalyser could not accurately predict previously reported TFs that can bind dense 
chromatin such as p53 and MyoD, possibly due to the absence of their co-factors, it means that the 
AIFs predicted by our model do not need co-factors for binding – but might still need co-factors to 
open the chromatin – otherwise ChIPanalyser, which does not include cooperativity as one of the 
modelling criterion, could have not properly predicted their binding patterns.  
 
GATA4, FOXA1 and CREB1 were respectively predicted as and ADF, partial AIF and AIF in the 
strongest sites of ATAC-seq and DNase-seq. The predictions for FOXA1 and CREB1 were expected, 
which is a positive sign of model reliability. Instead, the pioneering properties of GATA4 were not 
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recovered. This could potentially be because GATA4 is recruited by an AIF rather than being and AIF 
itself. Moreover, a recent study from 2019, however, proposed a model to explain GATA4’s DNA-
binding properties as a cooperative complex with TBX5. This GATA4:TBX5 complex has a role in 
normal heart development (Rosado‐Rodríguez, Rodríguez‐Ríos and Rodríguez‐Martínez, 2019). 
Influenced by the need for cooperativity, ChIPanalyser’s results in predicting GATA4 binding 
properties might have also been affected, like with p53 and MYOD. It is hypothesised that co-factor 
expression affects the binding mechanisms of some TFs and perhaps leads to increased pioneering 
activity at target sites (Donaghey et al., 2018). 
 
8.3 Interpreting ChIPanalyser’s results 
 
We used ChIPanalyser to computationally assume that 100% of the chromatin was accessible and 
TFs could bind everywhere (QDA=0, i.e. 0% of the chromatin is dense, 100% is accessible), to then 
compare the predicted profile with the real, experimentally obtained one. By assuming that the TF 
can bind everywhere according to the model, one could see if there are more peaks predicted in 
inaccessible DNA compared to another TF which binding was not restricted but predicted fewer 
peaks in dense chromatin. In this case the first TF would be a traditional TF which binding is 
restricted by DNA accessibility levels, whilst the second would bind regardless of the chromatin 
accessibility restrictions. This means that an AIF does not have predicted peaks in dense chromatin, 
whilst ADFs do. In other words, the fact that there is no predicted binding in dense chromatin is a 
suggestion of a potential AIF.  
  
We also assumed that TF binding was restricted only to small areas of accessible DNA (e.g. QDA=0.9, 
i.e. 90% of the chromatin is dense) and gained mechanistical and biological insights about the 
binding of that TF. By running ChIPanalyser assuming that 90% of the chromatin is dense, we 
distinguished between an AIF and an IDF because an insulator has ChIP peaks which are present 
only in dense chromatin, while an AIF will display peaks only in open chromatin.  
 
8.4 Limitations of this study 
 
8.4.1 Limitations with accessibility datasets 
 
This dissertation aimed to characterise 20 TFs in the IMR90 and HepG2 cell lines. Moreover, the 
analysis was run multiple times with different QDAs (1 to 12) which were used in order to investigate 
the preference of each TF for chromatin accessibility. Each QDA considers accessible the top 1-n 
regions for every DNA accessibility assay used (ATAC-seq, DNase-seq, MNase-seq and NOMe-seq). 
A QDA of 0, theoretically, should correspond to 1-0 regions being accessible (i.e. all regions will be 
accessible). On the contrary, a QDA of 0.99 should mean that 1-0.99 regions are open (i.e. 1% is 
accessible, 99% is dense). 
 
Having said that, it must be noted that the levels of accessible DNA varied amongst the four DNA 
accessibility assay used, as shown in fig. 10. A QDA of 0.9 did not always correspond to 90% of dense 
chromatin – this was especially true for the MNase-seq and NOMe-seq datasets. Such variability 
comes from the fact that these are different methods of measuring DNA accessibility. Specifically, 
the MNase-seq technology is based on the fact that the DNA that is not wrapped around 
nucleosomes will be digested, hence MNase-seq signals correspond to regions where the 
nucleosomes are bound. These correspond to the non-accessible regions. Then, in order to obtain 
the accessible ones, the signal is normalised to be comparable with the other datasets. Having done 
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that, the problem persisted in that a QDA≥0.9 did not correspond to 1-0.9 accessible region (0.1 i.e. 
10%), but it was 60-47%, meaning some quantiles did not match the accessibility percentages. One 
explanation could be that many regions in the MNase-seq datasets had missing signals, meaning 
that they were not covered, probably because reads did not align. It is hypothesised that the MNase-
seq we used had missing data and although there was binding, there was no accessibility data 
available. Since we want to measure accessible regions, if the heterochromatin repetitive elements 
are in dense chromatin they will not show as accessible. This means that certain regions might be 
inaccessible even though in certain regions the reads do not map. This could justify why most of the 
TFs in medium and weak-bound validation regions are poorly predicted. In order to correct for this 
condition, we could have selected specific regions where signals are present instead of running the 
analysis genome-wide. Moreover, another difficult relationship to unravel was the one between 
DNA methylation and nucleosome occupancy, which is what the NOMe-seq dataset measures. In 
this analysis, the DNA methylation patterns were difficult to align, as a QDA of 0 corresponded to 
41% accessible regions rather than 100%. The MNase-seq and NOMe-seq results, therefore, needed 
to be interpreted taking these limitations into account. Overall, these patterns suggest that these 
two methods do not have the dynamic range to distinguish well between different levels of 
accessibility. 
 
8.4.2 Explaining why some TFs are poorly predicted by ChIPanalyser 
 
In addition to noticing that the MNase-seq and NOMe-seq datasets followed a different pattern of 
accessibility levels compared the expected one (which was instead what we observed in ATAC-seq 
and DNase-seq datasets), it is also important to notice how much better ChIPanalyser did in 
predicting the TFs’ binding properties in the top-bound regions compared to the medium and weak-
bound. Better prediction in strong bound regions is a feature of almost all tools, both biophysical 
(Kaplan et al., 2011) and machine learning (Martin and  Zabet, 2020). The fact that the model 
performs well in strong-bound region but that we observe less and less TF binding events as the 
validation regions become weaker-bound suggests that the binding event is not driven by any of the 
four parameters that ChIPanalyser considers, which are DNA accessibility, binding energy, binding 
motif or the concentration of the TF bound to the DNA. Simply put, it must be something outside of 
those four criteria, something that is not taken into account by any of these models. For example, 
some of these TFs might work cooperatively, and as a matter of fact cooperative binding is not one 
of ChIPanalyser’s modelled features. This hypothesis was supported by Nagy et al. in 2016 where 
they showed that RAD21 and SMC3, which are both part of the pool of 20 TFs analysed in IMR90 
and HepG2, are cohesin subunits and as such they do not bind specifically to the DNA as they do not 
have a sequence preference. The DNA is extruded by the cohesin subunits RAD21 and SMC3 and 
this extrusion is blocked at CTCF sites (Schwarzer et al., 2017). This is just one instance that could 
explain the drop in model performance at the lower affinity binding sites. Looking into this limitation 
is important because it might mean that an AIF shows pioneering properties only at the strong-
bound sites. Another hypothesis regarding the behaviour of RAD21 and SCM3 is that they bind to 
the DNA without help from other TFs and then get stopped at CTCF sites. RCOR1 and ELK1 were also 
predicted poorly; again, perhaps they need co-factors for cooperativity or are sensitive to DNA 
methylation, neither of which possibilities were explored in this thesis. According to a 2016 paper 
by Lu, Mucaki and Rogan, 2016, RCOR1 is also a non-DNA binding protein and, as such, will not have 
specific sequence preferences (Lu, Mucaki and Rogan, 2016).  
 
Moreover, ChIPanalyser also did not perform well in predicting the properties of some previously 
reported AIFs in the literature such as p53 and MyoD that indeed were poorly predicted throughout 
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the whole of the analysis. One plausible explanation could be that AIFs need more co-factors than 
the average TF, hence why the issue with recovering some of their binding properties. Recent work 
confirmed binding of p53 to cis-regulatory elements, which are non-coding segments of DNA that 
control transcription through the combinatorial binding of local TFs (Catizone et al., 2020). These 
co-regulatory factors and local sequences acting at p53-bound cis-regulatory elements are 
comparatively understudied. The data suggest that p53 has the flexibility to cooperate with a 
multitude of TFs in order to regulate cis-regulatory elements’ activity. These findings support the 
hypothesis that p53 would be poorly predicted without its co-factors that are indeed essential for 
its binding. They hypothesised that global p53 activity is guarded against loss of any one regulatory 
partner, allowing for dynamic and redundant control of p53-mediated transcription. Martin and 
Zabet in 2020 showed that cooperative TFs such as Hox are poorly predicted by ChIPanalyser, 
therefore these results are expected. Another recent study revealed new insights into how p53 and 
p63 (previously reported AIFs regulating chromatin structure) can both positively and negatively 
influence each other to direct cell fate (Woodstock, Sammons and Fischer, 2021). Both AIFs appear 
to regulate a mostly unique set of target genes and have non-overlapping cellular roles, however 
evidence suggests that p53 and p63 cooperate to regulate DNA damage-induced apoptosis in mouse 
embryonic fibroblasts (Flores et al., 2002). Therefore, both studies offer strong support to claim that 
ChIPanalyser could not accurately predict p53 due to the absence of its co-factors.  
 
The second known AIF that we analysed in IMR90 as positive control is MyoD. The MyoD gene family 
encode transcription factors that are essential regulators of skeletal muscle lineage determination 
and differentiation in vertebrates (L'honore et al., 2003). MyoD is a well-established AIF in myogenic 
cell lineage specification during development and trans-differentiation. Its role is to regulate the 
expression of myogenic specific genes through its binding to regions containing cis-regulatory 
elements. MyoD also constitutively binds at tens of thousands of additional sites throughout the 
genome in proliferating muscle stem cells (Chen et al., 2020). Nonetheless, ChIPanalyser was not 
able to recover its binding properties. In 2003, L’Honore et al. showed that the distal regulatory 
region of the MyoD gene contains a conserved SRF (serum response factor) binding CArG-like 
element (CArG boxes are present in the promoters of smooth muscle cell genes), which is involved 
in the control of the gene expression in skeletal myoblasts and in mature muscle satellite cell 
activation during muscle regeneration. This MyoD-CArG sequence is active in modulating 
endogeneous MyoD gene expression because microinjection of oligonucleotides corresponding to 
the MyoD-CArG sequence specifically and rapidly suppressed MyoD expression in myoblasts 
(L'honore et al., 2003). These findings could explain once again why the model predictions are poor. 
 
 
8.5 Further work and conclusions 
 
Cross-referencing with known pioneer TFs in the same cell line is one approach for proof of concept. 
The question is then to distinguish between a pioneer and a co-factor of a pioneer, which would 
require further analysis (Jiang et al., 2019). For example, one could computationally hypothesise a 
TF’s pioneering properties with ChIPanalyser. Then in order to validate them, the analysis needs to 
be complemented by experimental set up where there is an overexpression of the TF, to then check 
if the predicted regions become open. By running ChIP-seq and ATAC-seq in the wild type and then 
in the overexpression mutant, one can compare whether in the mutant there are more open sites, 
in which case we know that that TF has accessibility independent properties. On the opposite, if 
there are no novel peaks, then that TF was probably one with accessibility dependent properties. 
This would be strong experimental evidence to the question “is this TF a pioneer?”. A TF with 
pioneering properties would never overlap with dense chromatin, because it would have already 
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opened it. However, unless every region where the supposedly AIF bound was open, it could not be 
excluded that the TF was accessibility dependent. Overall, it can be concluded that one cannot get 
the definite answer to such questions using solely a computational approach, but ChIPanalyser can 
work as a filter to classify TFs and shortlist the possible ADFs, AIFs and IDFs without running multiple 
wet-lab experiments. Also, ChIPanalyser allows to look at the bigger picture compared to individual 
patterns without the need for previous experimental data, if used for prediction. However, it is 
important to mention that the model is restricted to whatever is included in it: for example, 
ChIPanalyser does not include cooperative binding as one of the parameters to explain a TF’s binding 
pattern. Therefore, predicting the binding properties of certain TFs will probably be inaccurate if 
they rely on factors which the model does not consider, just like the aforementioned TFs SMC3 and 
RAD21. 
 
DNA methylation could be responsible, together with cooperative binding, for the drop in model 
performance observed in the weaker-bound regions. It is known that, in some cases, DNA 
methylation impacts some TFs’ binding: a recent study showed that while many TFs do not affect 
the methylation status of their binding sites, a group of AIFs called protective pioneer transcription 
factors (PPFs) prevent acquisition of DNA methylation, while another group called super pioneer 
transcription factors (SPFs) induce DNA demethylation at their methylated binding sites (Vanzan et 
al., 2021). Importantly, the authors of that study also showed that SOX2 inhibits DNMT-1 dependent 
maintenance of methylation during replication and that this inhibition is amplified by the co-binding 
of OCT4. However, enhancing chromatin accessibility is not achieved by the mechanism of this 
binding and the resulting demethylation alone, but interaction with multiple TFs is likely to be 
required too.  
 
As we did not include DNA methylation in our analysis, it might be that some of the differences in 
the model performance come from this. The relationship between TFs and DNA methylation does 
not appear to be a straightforward one: although it has been long thought that DNA methylation 
represses TF binding, a more recent study has proposed that actually TF binding can inhibit DNA 
methylation (Héberlé and Bardet, 2019). DNA methylation and TFs do, in fact, affect each other, in 
a number of different scenarios: for example, the shape of DNA – i.e. its 3D structure – has been 
thought to affect TF binding. Moreover, epigenetic regulation such as nucleosome positioning and 
histone modifications can also modulate the physical access of TFs to DNA (Slattery et al., 2014). 
The views regarding the sensitivity of TFs to DNA methylation are changing with emerging studies: 
it is now hypothesised that DNA methylation could be a consequence of TF binding, rather than a 
cause (Héberlé and Bardet, 2019 and Blattler and Farnham, 2013). In fact, established models 
suggest that DNA methylation represses TF binding, whilst emerging models suppose that TF binding 
to methylated regions induces demethylation. According to a recent 2019 study by Héberlé and 
Bardet, there are four possible scenarios by which TF binding could impact DNA methylation: firstly, 
TF binding to DNA promotes DNA methylation (e.g. MYC): when TFs bind to unmethylated DNA, 
recruitment of enzymes called DNA methyltransferases (DNMTs), responsible for the transfer of a 
methyl group to DNA, promotes de novo DNA methylation. Secondly, TF binding to DNA triggers 
DNA demethylation (e.g. CTCF): TFs recruit TET proteins, enzymes that catalyse the demethylation 
of 5-methylcytosine (Yang et al., 2020 and Wiehle et al., 2019), thereby triggering DNA 
demethylation. Thirdly, TF binding to DNA does not affect methylated regions, therefore they are 
maintained (e.g. ZFP57): in this case, transcriptional repression is maintained due to the binding of 
methyl-CpG-binding domains (MBDs) to methylated genomic islands (called mCpGs), which inhibits 
TF binding to CpG-rich regions. Lastly, TF binding to DNA does not affect unmethylated regions, 
therefore they are maintained (e.g. CFP1): a transcriptionally active state is recognised and 
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maintained thanks to TF binding which protects from de novo methylation by DNMTs. To conclude, 
the link between DNA methylation and TF binding appears to be variable and dependent upon 
factors such as the presence of mCpGs at specific positions within TF motifs. This means that there 
is not one specific model that fits all cases with regards to TF binding to methylated/unmethylated 
DNA. Instead, TF sensitivity is variable: the same TF could be responsive to a methylated genomic 
area and indifferent when CpGs are unmethylated (Héberlé and Bardet, 2019). 
 
In order to conduct the TF:methylated DNA parallel study, QDMs (quantile density methylation) 
could be used instead of QDAs, where the top methylated parts of the DNA as well as the least 
methylated ones are leveraged to understand whether a specific TF (i) prefers binding to methylated 
DNA, (ii) avoids methylated DNA or (iii) is indifferent to DNA methylation conditions. The hypothesis 
is that AIFs are indifferent to DNA methylation levels and can therefore bind with no preference to 
methylated or unmethylated DNA. There are also numerous TFs that show poor model prediction 
when 100% of DNA is considered accessible, whilst such prediction precision increases towards the 
top accessible regions. Considering this as further work following this project, instead of varying the 
top accessible regions, it could be interesting looking at the top methylated vs the top un-
methylated regions to observe if any sensitivity in TF binding is observed there. TFs could be 
classified based on whether they have this sensibility or not. Investigating the interplay between TF 
binding and DNA methylation is therefore one plausible application for ChIPanalyser. 
 
In conclusion, then, ChIPanalyser can be used to model and predict ChIP-seq data and learn new 
biological insights; it can be used to predict TF binding events between cell lines with partial data in 
a cell line, or for a screening process in order to understand what type of behaviour is associated to 
a TF. This model has the potential to be applied to any cell line. It is concluded that, regardless of 
the limitations discussed above, most of the predictions made by ChIPanalyser so far are in line with 
published data and, therefore, ChIPanalyser has been proved to be a valid predictive tool. These 
results will hopefully allow to gain new insights into the mechanisms of TF binding and open up new 
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